Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic
International Journal of Infectious Diseases Aug 31, 2021
Bhanuprasad K, Manesh A, Devasagayam E, et al. - In India, an unprecedented surge of mucormycosis appeared during COVID-19, particularly during the second wave.
Risk factors driving the epidemic of COVID-19 associated mucormycosis (COVID-Mucor) were analyzed among 164 participants: 132 COVID-Mucor (cases) and 32 non-COVID-Mucor (controls).
The primary drivers included uncontrolled diabetes, steroid use and probably COVID-19.
For prevention, recommended are judicious steroid use, screening and control of hyperglycemia.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
